Key result
Amiodarone discontinuation, prednisone, and cryoablation successfully control refractory AF in amiodarone-induced thyrotoxicosis.
Why the study?
The development of amiodarone-induced thyrotoxicosis can substantially complicate the management of cardiac arrhythmias, posing a major clinical challenge.
Case Report (n=1)
No
This case illustrates the complex management of amiodarone-induced thyrotoxicosis, demonstrating that achieving euthyroidism with glucocorticoids and utilizing catheter ablation can allow for the safe reintroduction of amiodarone when necessary.
Amiodarone-induced thyrotoxicosis may disrupt arrhythmia control; this case leaves open optimal steroid-plus-ablation strategies before routine adoption.
Amiodarone-induced thyrotoxicosis (AIT) is a serious thyroid dysfunction that represents a significant complication of pharmacological therapy in cardiology patients. The development of AIT can substantially complicate the management of cardiac arrhythmias, posing a major clinical challenge. We present the case of a patient in whom amiodarone was initially effective in the treatment of atrial fibrillation but subsequently led to type II amiodarone-induced thyrotoxicosis and exacerbation of the atrial arrhythmia. This case highlights the need for regular monitoring of patients treated with amiodarone, the challenges of managing arrhythmias in the setting of AIT, and the importance of close collaboration between cardiologists and endocrinologists in the diagnosis and treatment of AIT.
No takes yet. Share an insight, caveat, or question.
Amielan et al. (2026) conducted a case report in Amiodarone-induced thyrotoxicosis (n=1). Amiodarone was evaluated. Amiodarone-induced thyrotoxicosis complicated arrhythmia management, requiring amiodarone discontinuation, prednisone therapy, and cryoablation to control atrial fibrillation and inappropriate ICD shocks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: